Form 8-K - Current report:
SEC Accession No. 0000950103-25-007603
Filing Date
2025-06-18
Accepted
2025-06-18 16:52:57
Documents
14
Period of Report
2025-06-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp229911_8k-pricing.htm   iXBRL 8-K 34578
2 EXHIBIT 99.1 dp229911_ex9901.htm EX-99.1 12486
3 GRAPHIC image_001.jpg GRAPHIC 3359
  Complete submission text file 0000950103-25-007603.txt   223072

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE blco-20250609.xsd EX-101.SCH 3008
5 XBRL LABEL FILE blco-20250609_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE blco-20250609_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT dp229911_8k-pricing_htm.xml XML 3663
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 251057587
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)